Delivery Order SPE2DB22D1041-SPE2DB25FTZE4

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FOSAMAX 70 MG TABLET medical products. The contract is a Delivery Order valued at $2,555.40 with a Firm Fixed Price pricing type and a completion date of July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAJQ8, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, with an ultimate completion date of January 13, 2025 and a ceiling value of $1,300.91. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,367.22 Firm Fixed Price Delivery Order contract is for the supply of FOSAMAX 70 MG TABLET, a pharmaceutical product, with a period of performance through February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FG1G9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,465.98 Firm Fixed Price Delivery Order contract is for the supply of FOSAMAX 70 MG TABLET with an ultimate completion date of May 30, 2024. Amerisourcebergen is the prime contractor on this award, which is not designated as a set-aside contract. The company also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,899.56 firm fixed-price delivery order contract is for the supply of FOSAMAX 70 MG Tablets to support federal healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,884.14 firm fixed-price delivery order is for the supply of the drug FOSAMAX 70 MG TABLET. The contract has an ultimate completion date of December 24, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,898.78, is for the delivery of FOSAMAX 70 MG TABLET pharmaceutical products. It has a firm fixed price and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, identified as SPE2DB22D3016|SPE2DB25FAKN8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, with a ceiling value of $2,803.57 and a completion date of January 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which Amerisourcebergen holds with the DLA Troop...
This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKYN1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order valued at $1,754.82, is for the supply of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $13,511.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 24, 2024. The contract is for the provision of FOSAMAX 70 MG TABLET, a medication used to treat osteoporosis. This award does not have a set-aside designation, indicating it was...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTZE4
    Delivery Order

This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTZE4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $17,693.67, is a Firm Fixed Price Delivery Order for the supply of FOSAMAX 70 MG TABLET. The contract has an ultimate completion date of January 22, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 5/21/25, 10:23 AM